| Q32 BIO INC. O.N. |
| USA |
| Gesundheit |
| US7469641051 / A4ZZ0Z |
| DB0 (Frankfurt) / QTTB (NASDAQ) |
| FRA:DB0, ETR:DB0, DB0:GR, NASDAQ:QTTB |
| - |
| https://www.q32bio.com/ |
|
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing biologic therapies for autoimmune and inflammatory diseases driven by immune system dysfunction. The company’s current programs center on restoring healthy immune balance ..
>Volltext.. |
| 250.18 Mio. EUR |
| 161.14 Mio. EUR |
| 47.39 Mio. EUR |
| 19.24 Mio. EUR |
| 29.79 Mio. EUR |
| 2.66 EUR |
| 4.67 Mio. EUR |
| 93.71 Mio. EUR |
| -17.49 Mio. EUR |
| 19.68 |
| - |
| - |
| - |
| - |
| - |
| - |
| Q32 BIO |
| 30.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|